Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00752752 · ClinicalTrials.gov registry record
The Acute Cardiovascular Effects of Marathon Running Using Magnetic Resonance Imaging
A clinical trial, sponsored by Corewell Health East.
- Completed
- Registry status
- 25
- Enrollment target
NCT00752752: Completed study, sponsored by Corewell Health East.
NCT00752752 is a clinical trial that has completed, run by Corewell Health East. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00752752 has completed, sponsored by Corewell Health East.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
Using blood testing and cardiac magnetic resonance imaging (MRI), the investigators aim to determine if there are necrotic areas of myocardium in participants who complete a marathon. In addition, the investigators aim to describe the acute and chronic structural abnormalities that occur as a result of endurance training. The study hypothesis is that myocardial necrosis is present in runners completing a marathon competition.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2008-09 |
| Est. Completion | 2010-05 |
What the finished NCT00752752 record still lists
NCT00752752 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00752752 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00752752 about?
NCT00752752 is a clinical study titled "The Acute Cardiovascular Effects of Marathon Running Using Magnetic Resonance Imaging". Using blood testing and cardiac magnetic resonance imaging (MRI), the investigators aim to determine if there are necrotic areas of myocardium in participants who complete a marathon. In addition, the investigators aim to describe the acute and chronic structural abnormalities that occur as a result...
What is the current status of trial NCT00752752?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2008-09. Estimated completion is 2010-05.
Who is sponsoring clinical trial NCT00752752?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia